Free Trial

Dianthus Therapeutics (DNTH) Institutional Ownership

Dianthus Therapeutics logo
$22.15 +0.38 (+1.75%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$22.16 +0.01 (+0.02%)
As of 01/31/2025 04:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Dianthus Therapeutics (NASDAQ:DNTH)

Current
Institutional Ownership
Percentage
47.53%
Number of
Institutional Buyers
(last 12 months)
34
Total
Institutional Inflows
(last 12 months)
$233.08M
Number of
Institutional Sellers
(last 12 months)
12
Total
Institutional Outflows
(last 12 months)
$29.43M
Get DNTH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Dianthus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DNTH Institutional Buying and Selling by Quarter

Dianthus Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
1/30/2025 Rhumbline Advisers35,933$783K0.0%+3.8%0.121%
1/23/2025 R Squared Ltd1,200$26K0.0%N/A0.004%
1/22/2025 KBC Group NV1,593$35K0.0%N/A0.005%
1/17/2025 SG Americas Securities LLC9,653$210K0.0%+9.2%0.033%
11/19/2024Barclays PLC41,684$1.14M0.0%+390.5%0.141%
11/16/2024Geode Capital Management LLC485,121$13.29M0.0%-2.8%1.639%
11/15/2024Barclays PLC41,684$1.14M0.0%+390.5%0.141%
11/15/2024Jane Street Group LLC20,316$556K0.0%N/A0.069%
11/15/2024Wellington Management Group LLP53,785$1.47M0.0%N/A0.182%
11/15/2024State Street Corp821,131$22.48M0.0%+101.4%2.774%
11/15/2024Point72 Asset Management L.P.437,700$11.98M0.0%+151.3%1.479%
11/15/2024Janus Henderson Group PLC949,334$25.94M0.0%+40.5%3.207%
11/15/2024HighVista Strategies LLC19,808$542K0.2%N/A0.067%
11/15/2024Point72 Asia Singapore Pte. Ltd.8,568$235K0.0%-78.3%0.029%
11/14/2024Fred Alger Management LLC9,633$264K0.0%+52.5%0.033%
11/14/2024Braidwell LP493,687$13.52M0.4%+34.6%1.668%
11/14/2024Vestal Point Capital LP395,000$10.82M0.8%-34.2%1.335%
11/14/2024Walleye Capital LLC30,000$821K0.0%N/A0.101%
11/14/2024MetLife Investment Management LLC13,939$382K0.0%+129.1%0.047%
11/13/2024Great Point Partners LLC275,000$7.53M2.2%-63.7%0.929%
11/13/2024FMR LLC4,403,148$120.56M0.0%+0.0%14.876%
11/12/2024Charles Schwab Investment Management Inc.165,929$4.54M0.0%+142.0%0.565%
11/7/2024Quest Partners LLC1,125$31K0.0%+112,400.0%0.004%
10/3/2024 SG Americas Securities LLC8,839$242K0.0%+104.0%0.030%
9/16/2024Cubist Systematic Strategies LLC20,976$543K0.0%-13.1%0.071%
8/19/2024Point72 Asset Management L.P.174,200$4.51M0.0%-50.5%0.594%
8/15/2024The Manufacturers Life Insurance Company9,102$236K0.0%N/A0.031%
8/15/2024Point72 Asia Singapore Pte. Ltd.39,504$1.02M0.2%+281.9%0.135%
8/14/2024Fred Alger Management LLC6,317$163K0.0%-82.6%0.022%
8/14/2024Cubist Systematic Strategies LLC20,976$543K0.0%-13.1%0.071%
8/14/2024Point72 DIFC Ltd12,900$334K0.0%N/A0.044%
8/14/2024Great Point Partners LLC757,929$19.62M3.8%+21.3%2.582%
8/14/2024Marshall Wace LLP108,199$2.80M0.0%-4.2%0.369%
8/9/2024Renaissance Technologies LLC88,604$2.29M0.0%-16.2%0.302%
8/9/2024Dimensional Fund Advisors LP19,726$510K0.0%-9.2%0.067%
8/9/2024Atlas Venture Life Science Advisors LLC136,979$3.55M0.4%-26.7%0.467%
8/9/2024WINTON GROUP Ltd10,238$265K0.0%N/A0.035%
8/8/2024American Century Companies Inc.30,432$788K0.0%+38.6%0.104%
8/1/2024 Rhumbline Advisers32,138$832K0.0%N/A0.109%
7/26/2024Bank of New York Mellon Corp80,935$2.10M0.0%+860.5%0.276%
Please take this warning seriously... (Ad)

I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as March 13th… Meaning you don’t have much time to prepare.

Click here like your financial health depends on it.
7/12/2024 SG Americas Securities LLC4,333$112K0.0%N/A0.015%
5/20/2024Virtu Financial LLC12,995$390K0.0%N/A0.044%
5/17/2024RA Capital Management L.P.2,333,000$69.99M0.9%N/A7.949%
5/16/2024Janus Henderson Group PLC375,044$11.25M0.0%N/A1.278%
5/16/2024Bain Capital Life Sciences Investors LLC2,992,028$89.76M7.2%N/A10.194%
5/14/2024StemPoint Capital LP43,456$1.30M0.3%N/A0.148%
5/10/2024Acadian Asset Management LLC4,012$120K0.0%-77.6%0.014%
5/10/2024Vanguard Group Inc.537,828$16.14M0.0%+250.0%1.833%
5/6/2024Atlas Venture Life Science Advisors LLC186,979$5.61M0.5%-21.1%0.637%
5/2/2024Hussman Strategic Advisors Inc.21,000$630K0.1%N/A0.072%
2/15/2024Octagon Capital Advisors LP554,000$5.76M0.9%+15.4%3.738%
2/14/2024Vestal Point Capital LP135,000$1.40M0.1%N/A0.911%
2/13/2024Tower Research Capital LLC TRC 2,430$25K0.0%N/A0.016%
12/6/2023Citigroup Inc.3,868$53K0.0%N/A0.026%
11/15/2023Laurion Capital Management LP36,393$497K0.0%N/A0.960%
11/14/2023Avidity Partners Management LP1,217,554$16.64M0.7%N/A32.125%
11/13/2023Atlas Venture Life Science Advisors LLC236,979$3.24M0.5%N/A6.249%
11/13/2023Acadian Asset Management LLC22,299$303K0.0%N/A0.588%
11/13/2023FMR LLC2,218,212$28.96M0.0%N/A58.497%
(Data available from 1/1/2016 forward)

DNTH Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DNTH shares?

During the previous two years, 44 institutional investors and hedge funds held shares of Dianthus Therapeutics. The most heavily invested institutionals were FMR LLC ($120.56M), Bain Capital Life Sciences Investors LLC ($89.76M), RA Capital Management L.P. ($69.99M), Janus Henderson Group PLC ($25.94M), State Street Corp ($22.48M), Avidity Partners Management LP ($16.64M), and Vanguard Group Inc. ($16.14M).Learn more on DNTH's institutional investors.

What percentage of Dianthus Therapeutics stock is owned by institutional investors?

47.53% of Dianthus Therapeutics stock is owned by institutional investors. Learn more on DNTH's institutional investor holdings.

Which institutional investors have been buying Dianthus Therapeutics stock?

Of the 39 institutional investors that purchased Dianthus Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Bain Capital Life Sciences Investors LLC ($2.99M), RA Capital Management L.P. ($2.33M), FMR LLC ($2.22M), Avidity Partners Management LP ($1.22M), Janus Henderson Group PLC ($648.71K), State Street Corp ($413.43K), and Vanguard Group Inc. ($384.18K).

How much institutional buying is happening at Dianthus Therapeutics?

Institutional investors have bought a total of 11,807,744 shares in the last 24 months. This purchase volume represents approximately $284.14M in transactions.

Which Dianthus Therapeutics major shareholders have been selling company stock?

Of the 12 institutional investors that sold Dianthus Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Great Point Partners LLC ($482.93K), Vestal Point Capital LP ($205K), Point72 Asset Management L.P. ($177.90K), Atlas Venture Life Science Advisors LLC ($100K), Point72 Asia Singapore Pte. Ltd. ($30.94K), Fred Alger Management LLC ($30.05K), and Renaissance Technologies LLC ($17.10K).

How much institutional selling is happening at Dianthus Therapeutics?

Institutional investors have sold a total of 1,084,621 shares in the last 24 months. This volume of shares sold represents approximately $29.43M in transactions.



This page (NASDAQ:DNTH) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners